We are live on
!
Find out more
MG
Markel Group Portfolio holdings
AUM
$11.9B
1-Year Est. Return
10.84%
This Fund
S&P 500
This Quarter
Est. Return
+10.42%
1 Year Est. Return
+10.84%
3 Year Est. Return
+61.32%
5 Year Est. Return
+81.47%
10 Year Est. Return
+339.07%
AUM
$3.97B
AUM Growth
+$425M
(+12%)
Cap. Flow
+$78.2M
Cap. Flow
% of AUM
1.97%
Top 10 Holdings %
Top 10 Hldgs %
44.42%
Holding
112
New
9
Increased
42
Reduced
4
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Deere & Co
DE
|
+$25.3M |
| 2 |
Unilever
UL
|
+$8.57M |
| 3 |
SLB Ltd
SLB
|
+$7.18M |
| 4 |
Liberty Broadband Class C
LBRDK
|
+$6.35M |
| 5 |
CDK
CDK Global, Inc.
CDK
|
+$6.27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$23.9M |
| 2 |
Brown & Brown
BRO
|
+$6.42M |
| 3 |
Automatic Data Processing
ADP
|
+$5.98M |
| 4 |
Liberty Media Series C
FWONK
|
+$5.79M |
| 5 |
Coca-Cola
KO
|
+$5.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 32.88% |
| 2 | Consumer Discretionary | 16.02% |
| 3 | Consumer Staples | 12.53% |
| 4 | Industrials | 11.33% |
| 5 | Healthcare | 11.26% |
Similar funds
LC
UE
PIF
PI
NYLIM
GLA
VIA
HTC
Markel Group's Q4 2014 Portfolio in Review
As of Q4 2014, Markel Group held 112 positions worth $3.97B, up 12% from $3.55B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Markel Group's Q4 2014 filing shows 9 new, 42 increased, 4 reduced and 6 closed positions. Its largest new stake was Liberty Broadband Class C: 129,000 shares worth $6.43M. The largest sale was Teva Pharmaceuticals, an estimated $23.9M.
By sector, the portfolio is most concentrated in Financials at 33% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
- Markel Group's largest Q4 2014 buy was Liberty Broadband Class C: 129,000 shares worth $6.43M.
- Markel Group added most to Deere & Co in Q4 2014, an estimated $25.3M increase.
- Markel Group's biggest Q4 2014 reduction was Brown & Brown, cutting an estimated $6.42M.
- Markel Group fully exited Teva Pharmaceuticals in Q4 2014, selling an estimated $23.9M.
- Markel Group's ten largest holdings make up 44% of its $3.97B portfolio in Q4 2014.
- Markel Group opened 9 new positions and closed 6 in Q4 2014.
- Markel Group's portfolio value rose 12% quarter-over-quarter to $3.97B.
Based on Markel Group's 13F filing for Q4 2014, filed 9 Feb 2015.